Metabolic syndrome and its components predict the development of arterial stiffening in a sample of adult men

ABSTRACT Background and Objective Metabolic syndrome (MS) and its components are associated with greater cardiovascular risk. A number of studies found a positive association between MS and vascular damage, but few observational studies evaluated the predictive role of MS on arterial stiffening (AS). Therefore, the aim of this study was to estimate the ability of MS and its components to predict the risk of AS in an 8-year follow-up of a sample of adult men (Olivetti Heart Study). Methods The analysis included 778 men without AS (pulse pressure >60 mmHg) at baseline. A positive diagnosis of MS was made by recognized criteria, if at least three components were present. Results At the end of the follow-up period, there was an incidence of 11% in AS. The percentage of participants that developed AS was greater in the MS group than those without MS, also after adjustment for main confounders (odds ratio: 2.5, 95% confidence interval: 1.3–4.9). The risk of AS also increased with increase in the numbers of MS elements (p for trend <.01). In addition, the analysis of the predictive role of the single MS component showed that high blood pressure (HBP) was the strongest predictor. Conclusions The results of this prospective study indicate a predictive role of MS on AS, independently of main confounders. In addition, HBP seems the strongest predictor of AS among MS components.

[1]  F. Galletti,et al.  Relationship between circulating leptin levels and arterial stiffness: a systematic review and meta-analysis of observational studies , 2020, High Blood Pressure & Cardiovascular Prevention.

[2]  F. Viazzi,et al.  Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy. , 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[3]  E. Schiffrin,et al.  Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. , 2020, Journal of hypertension.

[4]  G. Grassi,et al.  Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis , 2020, Blood pressure.

[5]  R. Facchetti,et al.  THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS. , 2020, European journal of internal medicine.

[6]  F. Galletti,et al.  Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men , 2019, Journal of Endocrinological Investigation.

[7]  G. Lip,et al.  Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology : ESH / ESC Task Force for the Management of Arterial Hypertension , 2019 .

[8]  S. Laurent,et al.  Interaction Between Hypertension and Arterial Stiffness: An Expert Reappraisal , 2018, Hypertension.

[9]  G. Parati,et al.  Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program , 2018, European Journal of Clinical Nutrition.

[10]  E. Schiffrin,et al.  Role of immune cells in hypertension , 2018, British journal of pharmacology.

[11]  G. Mancia,et al.  Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study , 2018, Journal of hypertension.

[12]  Zhiheng Chen,et al.  The comorbidity of increased arterial stiffness and microalbuminuria in a survey of middle-aged adults in China , 2018, BMC Cardiovascular Disorders.

[13]  A. Avolio,et al.  Smooth muscle cell and arterial aging: basic and clinical aspects , 2018, Cardiovascular research.

[14]  P. Strazzullo,et al.  Excess Body Weight, Insulin Resistance and Isolated Systolic Hypertension: Potential Pathophysiological Links , 2018, High Blood Pressure & Cardiovascular Prevention.

[15]  L. D’elia,et al.  Effect of statin therapy on pulse wave velocity: A meta-analysis of randomized controlled trials , 2018, Clinical and experimental hypertension.

[16]  A. de la Sierra,et al.  Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study , 2018, Journal of hypertension.

[17]  F. Galletti,et al.  Effect of dietary sodium restriction on arterial stiffness: systematic review and meta-analysis of the randomized controlled trials , 2017, Journal of hypertension.

[18]  R. Hegele,et al.  The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation[S] , 2017, Journal of Lipid Research.

[19]  P. Challande,et al.  SRF/myocardin: a novel molecular axis regulating vascular smooth muscle cell stiffening in hypertension. , 2017, Cardiovascular research.

[20]  S. Studenski,et al.  Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging , 2017, Hypertension.

[21]  F. Galletti,et al.  The Olivetti Heart Study: Predictive value of a new adiposity index on risk of hypertension, blood pressure, and subclinical organ damage. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[22]  V. Gudnason,et al.  Pulse Pressure Relation to Aortic and Left Ventricular Structure in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study , 2014, Hypertension.

[23]  N. Ewald,et al.  Current knowledge of hypertriglyceridemic pancreatitis. , 2014, European journal of internal medicine.

[24]  A. Tedgui,et al.  Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis , 2014, Circulation research.

[25]  J. Coresh,et al.  GFR estimation: from physiology to public health. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  A. Hofman,et al.  Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. , 2014, Atherosclerosis.

[27]  F. Galletti,et al.  Not smoking is associated with lower risk of hypertension: results of the Olivetti Heart Study. , 2014, European journal of public health.

[28]  Daniel F. Freitag,et al.  Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. , 2014, European heart journal.

[29]  A. Cote,et al.  Childhood obesity and cardiovascular dysfunction. , 2013, Journal of the American College of Cardiology.

[30]  R. Touyz,et al.  Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. , 2013, Antioxidants & redox signaling.

[31]  S. Kardia,et al.  Metabolic syndrome is associated with change in subclinical arterial stiffness - A community-based Taichung Community Health Study , 2011, BMC public health.

[32]  Sung-il Cho,et al.  Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. , 2010, Atherosclerosis.

[33]  A. Levin,et al.  Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. , 2009, Cardiovascular research.

[34]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[35]  G. Mancia,et al.  The metabolic syndrome in hypertension: European society of hypertension position statement , 2008, Journal of hypertension.

[36]  E. Meaney,et al.  METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY , 2008, Clinical and experimental pharmacology & physiology.

[37]  F. Cappuccio,et al.  Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. , 2008, Metabolism: clinical and experimental.

[38]  H. Makino,et al.  Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system , 2008, Journal of hypertension.

[39]  B. Davis,et al.  Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2008, Archives of internal medicine.

[40]  F. Cappuccio,et al.  Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study , 2007, Journal of hypertension.

[41]  H. Hashimoto,et al.  The Effects of Changes in the Metabolic Syndrome Detection Status on Arterial Stiffening: A Prospective Study , 2006, Hypertension Research.

[42]  B. Pannier,et al.  Metabolic syndrome and age-related progression of aortic stiffness. , 2006, Journal of the American College of Cardiology.

[43]  In-kyu Lee,et al.  Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. , 2005, Journal of the American Society of Nephrology : JASN.

[44]  G. Doronzo,et al.  Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance , 2004, European journal of clinical investigation.

[45]  Pasquale Strazzullo,et al.  Altered Renal Handling of Sodium in Human Hypertension: Short Review of the Evidence , 2003, Hypertension.

[46]  Arya M. Sharma,et al.  Hormonal regulation of the human adipose-tissue renin–angiotensin system: relationship to obesity and hypertension , 2002, Journal of hypertension.

[47]  D. Kass,et al.  Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker , 2001, Circulation.

[48]  J D Swales,et al.  Effect of Aging on the Prognostic Significance of Ambulatory Systolic, Diastolic, and Pulse Pressure in Essential Hypertension , 2001, Circulation.

[49]  R. Asmar,et al.  Reference values for clinic pulse pressure in a nonselected population. , 2001, American journal of hypertension.

[50]  A. Bihorac,et al.  Association between salt sensitivity and target organ damage in essential hypertension. , 2000, American journal of hypertension.

[51]  S. Yamashita,et al.  Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. , 1998, Metabolism: clinical and experimental.

[52]  P. Guillausseau,et al.  Diabetes, advanced glycation endproducts and vascular disease , 1998, Vascular medicine.

[53]  M. Daemen,et al.  Effects of Chemical Sympathectomy on Angiotensin II-Induced Neointimal Growth in the Balloon-Injured Rat Carotid Artery , 1998, Journal of Vascular Research.

[54]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[55]  F. Yin,et al.  Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. , 1995, Hypertension.

[56]  R. Havel,et al.  Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[57]  S. Azen,et al.  Triglyceride‐ and Cholesterol‐Rich Lipoproteins Have a Differential Effect on Mild/Moderate and Severe Lesion Progression as Assessed by Quantitative Coronary Angiography in a Controlled Trial of Lovastatin , 1994, Circulation.

[58]  M. Safar,et al.  Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR. Role of angiotensin converting enzyme inhibition. , 1990, Circulation research.

[59]  H. Halkin,et al.  Elevated serum uric acid — a facet of hyperinsulinaemia , 1987, Diabetologia.

[60]  G. Mancia,et al.  Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies , 2018, Journal of hypertension.